| Company Name: |
Shanghai Aladdin Bio-Chem Technology Co.,LTD
|
| Tel: |
400-400-6206333 18521732826 |
| Email: |
market@aladdin-e.com |
| Products Intro: |
Product Name:17(R)-Resolvin D1
CAS:528583-91-7
Purity:~0.01% in ethanol,>=95% Package:10μg/RMB 4119.90;25μg/RMB 7827.90
|
| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:17(R)-Resolvin D1
CAS:528583-91-7
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:17(R)-Resolvin D1
CAS:528583-91-7
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:17(R)-Resolvin D1
CAS:528583-91-7
Purity:95% Package:10μg;25μg;50μg
|
|
| | 7S,8R,17R-TRIHYDROXY-4Z,9E,11E,13Z,15E19Z-DOCOSAHEXAENOIC ACID Basic information |
| Product Name: | 7S,8R,17R-TRIHYDROXY-4Z,9E,11E,13Z,15E19Z-DOCOSAHEXAENOIC ACID | | Synonyms: | 17(R)-RESOLVIN D1;17(R)-RVD1;7S,8R,17R-TRIHYDROXY-4Z,9E,11E,13Z,15E19Z-DOCOSAHEXAENOIC ACID;4,9,11,13,15,19-Docosahexaenoic acid, 7,8,17-trihydroxy-, (4Z,7S,8R,9E,11E,13Z,15E,17R,19Z)-;OIWTWACQMDFHJG-BJEBZIPWSA-N | | CAS: | 528583-91-7 | | MF: | C22H32O5 | | MW: | 376.49 | | EINECS: | | | Product Categories: | | | Mol File: | 528583-91-7.mol |  |
| | 7S,8R,17R-TRIHYDROXY-4Z,9E,11E,13Z,15E19Z-DOCOSAHEXAENOIC ACID Chemical Properties |
| Boiling point | 609.2±55.0 °C(Predicted) | | density | 1.101±0.06 g/cm3(Predicted) | | storage temp. | Store at -80°C | | solubility | DMF: 50 mg/ml; Ethanol: 50 mg/ml; PBS (pH 7.2): 0.05 mg/ml | | pka | 4.58±0.10(Predicted) |
| | 7S,8R,17R-TRIHYDROXY-4Z,9E,11E,13Z,15E19Z-DOCOSAHEXAENOIC ACID Usage And Synthesis |
| Uses | 17(R)-Resolvin D1 is an exhibitor of a dose-dependent reduction in leukocyte infiltration.is used in methods for predicting patient response to disease-modifying antirheumatic drug (DMARD). | | Definition | ChEBI: Aspirin-triggered resolvin D1 is a member of the class of resolvins that consists of docosa-4Z,9E,11E,13Z,15E,19Z-hexaenoic acid carrying three hydroxy substituents at positions 7, 8, and 17 (the 7S,8R,17S-stereoisomer). It has a role as an anti-inflammatory agent, an antiviral agent, an analgesic, a TGFbeta receptor antagonist, a nephroprotective agent, an anti-allergic agent and a human xenobiotic metabolite. It is a resolvin, a secondary allylic alcohol and a hydroxy polyunsaturated fatty acid. |
| | 7S,8R,17R-TRIHYDROXY-4Z,9E,11E,13Z,15E19Z-DOCOSAHEXAENOIC ACID Preparation Products And Raw materials |
|